At Close: 4:00 PM
Pre Market: 4:05 AM
Immunic, Inc. 1 Year - Performance
The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism.
However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators.
Comparing their expectations to the market could help investors estimate their prospective return.
Frequently Asked Questions
How is IMUX price-to-earnings ratio currently?
IMUX has a current P/E ratio of N/A.
How are IMUX's price-to-sale and price-to-book ratios?
The IMUX stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 0.63.
Is Immunic, Inc.'s price-to-cash ratio high or low?
IMUX's price-to-cash (P/C) ratio is 1.26, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for IMUX?
Based on IMUX's recent bid, its distance from 20 days simple moving average is 42.72%. It is 59.16% apart from 50 days simple moving average, and it is -43.53% apart from 200 days simple moving average.
What is the 52-week price range for IMUX?
The 52-week high for IMUX is $14.50 which is 0.85% away from the current price level whereas the distance of that from the 52-week low of $1.11 stands at 1.02%.
An overview of IMUX's stock performance: how did it fare?
The performance of IMUX stock was encouraging with all of its significant price indictors in green. Immunic, Inc. (NASDAQ: IMUX) shares have moved upward 8.21% or $0.17 in the latest trading session and have gained 60% year-to-date (YTD). The stock has loss nearly -79.41% over the past year. After moving 21.08% over the trailing 3-month period, the stock is -35.26% lower in the 6-month period. Looking at its performance over the shorter term, it's up 20.43% a week and 75% a month.
What is IMUX's 14-day relative strength index (RSI)?
The current 14-day RSI for IMUX stock is 76.81. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For IMUX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Immunic, Inc. (IMUX) has a 14-day ATR of 0.17.
What is IMUX's current enterprise value?
After closing at $2.24 with 44.36 Million of its shares outstanding, the current enterprise value of IMUX is roughly N/A.
Over the past year, how has the stock price of IMUX changed?
Immunic, Inc. (NASDAQ: IMUX) is up N/A when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of N/A. IMUX stock price is also up 60% on its value in year-to-date trading.
What is the average trading volume for IMUX shares?
The number outstanding shares of IMUX is 44.36 Million, and of these 36.07 Million shares are freely available for trading. On average, IMUX stock has traded 1.52 Million shares per day for the past 10 days. A total of 1.82 Million shares changed hands during the last trading session with the average session volume of 1.16 Million shares.